PROCEPT BioRobotics (PRCT) FCF Margin Growth (3y) (2023 - 2026)
PROCEPT BioRobotics (PRCT) FCF Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn | -2,196.00 |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn | -472.00 |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 2,679.00 |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn | -20.00 |
| 10 | PROCEPT BioRobotics | 995.72 Mn | 750.08 Mn | 53.95 Mn | 11,973.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,973.00 |
| Dec 31, 2025 | 9,732.00 |
| Sep 30, 2025 | 9,359.00 |
| Jun 30, 2025 | 7,904.00 |
| Mar 31, 2025 | 10,433.00 |
| Dec 31, 2024 | 11,844.00 |
| Sep 30, 2024 | 11,967.00 |
| Jun 30, 2024 | 12,046.00 |
| Mar 31, 2024 | 13,812.00 |
| Dec 31, 2023 | 39,512.00 |